KCG
HALO icon

Knight Capital Group’s Halozyme HALO Stock Holding History

Knight Capital Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$217K Buy
+27,366
New +$174K ﹤0.01% 2614

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Knight Capital Group's HALO Position: Q2 2013 in Review

Knight Capital Group opened a new position in Halozyme (HALO) in Q2 2013: 27,366 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings.

110 funds tracked by Wall St. Rank hold HALO as of Q2 2013.

  • Knight Capital Group held 27,366 shares of Halozyme worth $217K as of Q2 2013.
  • Halozyme was a new Knight Capital Group position in Q2 2013.
  • Halozyme made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2614 holding.
  • 110 funds tracked by Wall St. Rank held Halozyme as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.